Beike Biotech Launches New International Stem Cell Venture
“Beike Holdings Limited”, a Strategic Joint Venture With Bangkok-Based SiriCell Technologies, Inc., Will Support the Rapid Clinical Translation of Stem Cell Therapies & Regulatory Approval Outside of China SHENZHEN, China,…
Lupus study shows promising results using umbilical cord mesenchymal stem cells. NANJING, Jiangsu, China, June 7, 2010 /PRNewswire-Asia/ — A new study shows that umbilical cord mesenchymal stem cell transplant…
Leading Chinese Stem Cell Therapy Provider Expands Capacity Ahead of Schedule TAIZHOU, China, May 11 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the world’s leading biotechnology companies focusing on…
Leading Chinese Stem Cell Therapy Provider Awarded Three ISO9001 Certifications for Stem Cell Technology Quality Management System TAIZHOU, China, April 2 /PRNewswire-Asia/ — Beike Biotechnology Co. Ltd., one of the…
TAIZHOU, Jiangsu, China, January 6 – The Jiangsu Government’s Science and Technology Department has announced a $1.8 million grant – the Jiangsu Technological Achievements Transformational Grant – to support the…
Beike CSO Speaks at IPA Diabetic Foot Care Conference, India
NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ — Dr. Susan Jiang, M.D., Ph.D., Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), spoke at a conference on High-Risk Diabetic…